Abstract:ABE variants with high editing efficiency and specificity are obtained through the designed library‐assisted evolution of TadA8e in the eukaryotic cell system. The resulting candidate variants, compared to ABE8e, demonstrate narrower editing window and reduced bystander efficiency as well as lower off‐targeting activity. The current‐generation adenine base editor (ABE) ABE8e, which has evolved from the prokaryotic evolution system, exhibits high efficiency in mediating A‐to‐G conversion and is presumed to be promising for gene therapy. However, its much wider editing window and substantially higher off‐target editing activity restricted its applications in precise base editing for therapeutic use. This study uses a library‐assisted protein evolution approach using eukaryotic cells to generate ABE variants with improved specificity and reduced off‐target editing while maintaining high activity in human cells. The study generated an expanded set of ABEs with efficient editing activities and chose four evolved variants that offered either similar or modestly higher efficiency within a narrower editing window of protospacer position ≈4–7 compared to that of ABE8e in human cells, which would enable minimized bystander editing. Moreover, these variants resulted in reduced off‐target editing events when delivered as plasmid or mRNA into human cells. Finally, these variants can install both disease‐suppressing mutations and disease‐correcting mutations efficiently with minimal undesired bystander editing making them promising approaches for specific therapeutic edits. In summary, the work establishes a mutant‐library‐assisted protein evolution method in eukaryotic cells and generates alternative ABE variants as efficient tools for precise human genome editing.

Systematic empirical evaluation of individual base editing targets: validating therapeutic targets in USH2A and comparison of methods

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA

Precision genome editing using cytosine and adenine base editors in mammalian cells

Effective Gene Editing by High-Fidelity Base Editor 2 in Mouse Zygotes

Improved specificity and efficacy of base-editing therapies with hybrid guide RNAs

Cytosine and Adenine Base Editing of the Brain, Liver, Retina, Heart and Skeletal Muscle of Mice Via Adeno-Associated Viruses

Direct delivery of stabilized Cas-embedded base editors achieves efficient and accurate editing of clinically relevant targets

Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos

Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

Engineering a Precise Adenine Base Editor with Minimal Bystander Editing.

Library‐Assisted Evolution in Eukaryotic Cells Yield Adenine Base Editors with Enhanced Editing Specificity

CRISPR single base-editing: in silico predictions to variant clonal cell lines

Activity-based selection for enhanced base editor mutational scanning

Therapeutic base editing of human hematopoietic stem cells

Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors

Adenine Base Editing in an Adult Mouse Model of Tyrosinaemia

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope

DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants

The Development and Application of a Base Editor in Biomedicine

Human cleaving embryos enable robust homozygotic nucleotide substitutions by base editors